文献速递临床微生物质量管理与危急值

抗微生物耐药实验室网络对ThermoFisher Sensititre GN7F肉汤微量稀释面板的多中心评估

Antimicrobial Resistance Laboratory Network's multisite evaluation of the ThermoFisher Sensititre GN7F broth microdilution panel for antimicrobial susceptibility testing.
PubMed 文献 · J Clin Microbiol · 2023-11-16

CDC和四家实验室评估Sensititre GN7F肉汤微量稀释面板,测试100株分离株(40株肠杆菌目、30株铜绿假单胞菌、30株鲍曼不动杆菌),比较不同转移体积(1、10、30、50 µL)对药敏试验准确性的影响。结果显示增加转移体积可提高肠杆菌目的基本一致率并减少极重大误差,但铜绿假单胞菌的重大误差也增加,鲍曼不动杆菌各体积均出现多种误差。

要点

  • 肠杆菌目使用标准转移体积时15种β-内酰胺中7种基本一致率<90%。
  • 增加转移体积至30 µL可提高肠杆菌目基本一致率并减少极重大误差。
  • 鲍曼不动杆菌在所有转移体积下均出现多种极重大误差和重大误差。

核心结论

  • 对GN7F面板,尤其对变形杆菌族,推荐将转移体积增加至30 µL,尽管属于超说明书使用。

研究设计与样本

  • CDC和四家实验室评估Sensititre GN7F肉汤微量稀释面板,测试100株分离株(40株肠杆菌目、30株铜绿假单胞菌、30株鲍曼不动杆菌)。
  • 比较转移体积1 µL(仅变形杆菌族)和10、30、50 µL,对应菌落形成单位每毫升分别为1×10^4、1×10^5、3×10^5、5×10^5。
  • 分析四种转移体积组合:标准(1 µL变形杆菌族+10 µL)、增强标准(1 µL变形杆菌族+30 µL)、30 µL、50 µL。

主要发现

  • 肠杆菌目使用标准和增强标准转移体积时,15种β-内酰胺中7种的平均基本一致率<90%;随转移体积增加,基本一致率>90%且极重大误差减少。
  • 铜绿假单胞菌基本一致率随转移体积增加而改善,但重大误差也增加。
  • 鲍曼不动杆菌增加转移体积仅轻微改善基本一致率,所有转移体积均产生多种极重大误差和重大误差。
  • 肠杆菌目和鲍曼不动杆菌使用1或10 µL转移体积时MIC呈下降趋势;铜绿假单胞菌无明显MIC趋势。

关键数值与推荐

  • 肠杆菌目:标准/增强标准转移体积下,15种β-内酰胺中7种平均基本一致率<90%;增加转移体积后基本一致率>90%。
  • 推荐GN7F转移体积为30 µL,尤其对变形杆菌族,尽管属于超说明书使用。

临床怎么用

  • 对GN7F面板进行药敏试验时,考虑将转移体积增加至30 µL以降低漏检耐药的风险。

局限性

  • 30 µL转移体积属于超说明书使用。
  • 鲍曼不动杆菌在所有测试转移体积下均出现多种极重大误差和重大误差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2017, the Centers for Disease Control and Prevention (CDC) established the Antimicrobial Resistance Laboratory Network to improve domestic detection of multidrug-resistant organisms. CDC and four laboratories evaluated a commercial broth microdilution panel. Antimicrobial susceptibility testing using the Sensititre GN7F (ThermoFisher Scientific, Lenexa, KS) was evaluated by testing 100 CDC and Food and Drug Administration AR Isolate Bank isolates [40 Enterobacterales (ENT), 30 Pseudomonas aeruginosa (PSA), and 30 Acinetobacter baumannii (ACB)]. We assessed multiple amounts of transfer volume (TV) between the inoculum and tubed 11-mL cation-adjusted Mueller-Hinton broth: 1 µL [tribe Proteeae (P-tribe) only] and 10, 30, and 50 µL, resulting in respective CFU per milliter of 1 × 104, 1 × 105, 3 × 105, and 5 × 105. Four TV combinations were analyzed: standard (STD) [1 µL (P-tribe) and 10 µL], enhanced standard (E-STD) [1 µL (P-tribe) and 30 µL], 30 µL, and 50 µL. Essential agreement (EA), categorical agreement, major error (ME), and very major error (VME) were analyzed by organism then TVs. For ENT, the average EA across laboratories was <90% for 7 of 15 β-lactams using STD and E-STD TVs. As TVs increased, EA increased (>90%), and VMEs decreased. For PSA, EA improved as TVs increased; however, MEs also increased. For ACB, increased TVs provided slight EA improvements; all TVs yielded multiple VMEs and MEs. For ENT and ACB, Minimum inhibitory concentrations (MICs) trended downward using a 1 or 10 µL TV; there were no obvious MIC trends by TV for PSA. The public health and clinical consequences of missing resistance warrant increased TV of 30 µL for the GN7F, particularly for P-tribe, despite being considered "off-label" use.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Bhatnagar AS, Machado M-J, Patterson L, et al. Antimicrobial Resistance Laboratory Network's multisite evaluation of the ThermoFisher Sensititre GN7F broth microdilution panel for antimicrobial susceptibility testing. J Clin Microbiol. 2023. PMID: 37971271. doi:10.1128/jcm.00799-23

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。